Why eye movements
Exam of the eye movements tells more than a kilometer walk
Eye movements help predict disease evolution up to 5 years
scientific papers link eye-tracking with disorders
An easy-to-use eye-tracking environment
to help practitioners instantaneously quantify their clinical exam
Based on years of research, it is designed to bring non-invasive, quick, and robust biomarkers.
neuroClues® has the ambition to provide:
neuroClues® is a registered brand of P3Lab, currently under research and development phase. It will be available for sale when regulatory clearance is received.
Our scientific advisory board testifies
Over the last 60 years, over 110 000 scientific articles have been written linking eye movement to neurological diseases
Eye-tracking enables measurements and analysis, allowing neurologists to increase their diagnosis certainty in few minutes and have a better follow-up of the patients. This innovative technology can be used for the diagnosis of Parkinson’s disease and other neurological diseases.
SfN poster: Evidence of an exogenous input to Superior Colliculus as a source of saccadic inhibition.
At this year’s Society for Neuroscience conference, our team presented preliminary evidence for a test that holds the potential to become a reference test in the pre-clinical
Your guide to navigating the SfN Welcome to Washington DC ! As the Society for Neuroscience’s annual meeting approaches, we are excited to present
An article written by our co-founders Antoine Pouppez and Pierre Pouget, and published on ADN: NeuroClues, a start-up developing a medical device based on eye-tracking,